Vision Fund investment portfolio company ArsenalBio's logo

ArsenalBio is fighting cancer by developing next generation T cell therapies.

Leadership
Ken Drazan
Fund
SVF2
Status
Private
Sector
Health Tech
Region
EMEA

Insights
Roundup
Data and ML are creating a golden age of drug discovery

The biotech sector is poised to reap the benefits of the AI revolution, with lifesaving effects